Anti-SARS-CoV-2 Spike S1 (RBD) Neutralizing Antibody (V3S-0623-XY38) (CAT#: V3S-0623-XY38)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description The antibody MW06 is a human mAb specific for SARS-CoV-2 Spike S1 protein. It is a fully human cross-reactive mAb, which binds to both SARS-CoV-2 and SARS-CoV spike receptor-binding domain and disrupts their interaction with angiotensin-converting enzyme 2 (ACE2) receptors. It recognizes a conserved epitope on SARS-CoV-2, which provides insights for the development of a universal antibody-based therapy against SARS-related coronavirus and emerging variant strains, and may be an effective anti-SARS-CoV-2 agent.
Clonality Monoclonal
Host Species Human
Target Species SARS-CoV-2
Cross Reactivity SARS-related coronavirus
Epitope Receptor-binding domain (RBD)
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA, Neut
Application Notes To access the binding of mAbs to recombinant proteins (SARS-CoV-2 RBD, SARS-CoV-2 RBD mutants, SARS-CoV RBD), recombinant proteins were coated on 96-well ELISA plates at 10 µg/ml in 100 µL at 4°C for overnight. After blocking with 5% bovine serum albumin in PBS, serially diluted mAbs were added to the plates and incubated at 37°C for 1 hour. Plates were washed and second_x0002_ary Ab Goat Anti-Human IgG Fc-HRP was added. TMB was used for color development and absorbance at 450 nm was measured using a microplate reader. For the RBD/ACE2-hFc blocking assay, ACE2-hFc recombinant protein was coated on a 96-well ELISA plate at 0.75 µg/ml in 100 µL at 4°C for overnight. The equivalent volumes (100 µL + 100 µL) of pre-incubated RBD-mFc/mAb complex were added to the plates and incubated for 1 hour at 37°C. Plates were washed and secondary Ab Goat Anti-Mouse IgG Fc-HRP was added. TMB was used for color development and absorbance at 450 nm was measured using a microplate reader.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Western Blot Protocol

Target

Target SARS-CoV-2
Alternative Name Severe acute respiratory syndrome coronavirus 2
Research Area Coronavirus Disease 2019
Related Disease Coronavirus Disease 2019
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry